NUTX — Nutex Health, Inc. stock price, charts and financials

NASDAQ·Healthcare·Medical - Care Facilities·USA

Latest market price

193.60

+31.53+19.46%

Overview Short InterestFilings

NUTXQT89Nutex Health, Inc.·NASDAQ

Overview Short InterestFilings

193.60+19.46%

Earnings

Up 19.5% — Q2 EPS beat estimate by 89% ($9.38 vs. $4.95), offsetting a 2% revenue miss.

High confidence

Loading chart...

Signal & projected range

Earnings big beat — drift (PEAD)Historical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

USPH+0.86%$80.74 PNTG+0.84%$39.33 AMN+1.47%$36.53 TALK+0.29%$5.24 INNV-2.14%$10.94 HCSG-1.03%$22.00 AGL+1.71%$97.14 ARDT-3.92%$11.10

Snapshot

Index	-	P/E	6.12	EPS (ttm)	26.48	Insider Own	-	Shs Outstand	6.88M	Perf Week	9.93%

Market Cap	1.12B	Forward P/E	7.04	EPS next Y	23.03	Insider Trans	0.00%	Shs Float	3.40M	Perf Month	-11.61%

Enterprise Value	1.23B	PEG	0.03	EPS next Q	5.26	Inst Own	-	Short Float	30.86%	Perf Quarter	20.42%

Income	184.80M	P/S	1.32	EPS this Y	67.08%	Inst Trans	-	Short Ratio	6.88	Perf Half Y	58.94%

Sales	846.70M	P/B	2.14	EPS next Y	7.02%	ROA	18.65%	Short Interest	1.05M	Perf YTD	-1.55%

Book/sh	-	P/C	3.06	EPS next 5Y	7.02%	ROE	47.97%	52W High	243.68 -20.55%	Perf Year	73.17%

Cash/sh	-	P/FCF	3.20	EPS past 3/5Y	- -15.75%	ROIC	33.39%	52W Low	92.23 109.91%	Perf 3Y	165.47%

Dividend Est.	-	EV/EBITDA	3.47	Sales past 3/5Y	58.68% 26.14%	Gross Margin	51.26%	Volatility	6.42% 5.80%	Perf 5Y	-

Dividend TTM	-	EV/Sales	1.45	EPS Y/Y TTM	32.65%	Oper. Margin	43.02%	ATR (14)	9.88	Perf 10Y	-

Dividend Ex-Date	-	Quick Ratio	4.96	Sales Y/Y TTM	83.33%	Profit Margin	21.25%	RSI (14)	53.76	Recom	2.00

Dividend Gr. 3/5Y	-	Current Ratio	5.00	EPS Q/Q	479.07%	SMA20	2.46%	Beta	2.10	Target Price	235.00

Payout	55.29%	Debt/Eq	0.62	Sales Q/Q	1.89%	SMA50	4.24%	Rel Volume	2.27	Prev Close	162.07

Employees	944	LT Debt/Eq	0.78	Earnings	Nov 17	SMA200	20.67%	Avg Volume	129.82K	Price	193.60

IPO Date	Apr 04, 2022	Option/Short	No / Yes	EPS/Sales Surpr.	63.27% -4.97%	Net Debt/EBITDA	0.31	Volume	294,764	Change	19.46%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Jun-02-26	Initiated	Lake Street	Buy	$235
Aug-26-25	Reiterated	Maxim Group	Buy	$45 → $205
Sep-18-24	Reiterated	Maxim Group		$45

Latest News

Aug-07-26

Aug-07-2612:05PM

Nutex Health Q2 Earnings Call Highlightsmarketbeat.com

Aug-06-26

Aug-06-2605:58PM

NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTSprnewswire.com

04:48PM

Nutex Health Q2 EPS $9.38 Beats $4.95 Estimate, Sales $210.752M Miss $215.031M EstimateBenzinga

Jul-21-26

Jul-21-2605:30AM

Nutex Health Schedules 2026 Second Quarter Financial Results Release and Conference Callprnewswire.com

Jul-07-26

Jul-07-2607:17AM

Why Nutex Health’s (NUTX) Microhospital Economics Put Reimbursement at the Center of Its Upside CaseYahoo

Jul-01-26

Jul-01-2612:29AM

Nutex Health Has A Healthy Pulse And Shows Strong Signs Of Life For Further GainsSeekingAlpha

Jun-26-26

Jun-26-2611:36AM

B. Riley Securities Initiates Coverage On Nutex Health with Buy Rating, Announces Price Target of $290Benzinga

Jun-20-26

Jun-20-2607:40AM

Nutex Looks Better, But Not Safe YetSeekingAlpha

Jun-19-26

Jun-19-2604:10AM

Nutex Health: Good Value But Regulation ReliantSeekingAlpha

Company

Nutex Health, Inc. functions as a technology-powered enterprise delivering healthcare services, structured into two key segments: its Hospital division and its Population Health Management division. The Hospital division is tasked with developing and overseeing various healthcare models, encompassing micro-hospitals, specialized medical centers, and hospital outpatient facilities. This segment currently owns and operates 21 locations spanning eight different states. Meanwhile, the Population Health Management division establishes and manages provider networks, such as independent physician associations. Additionally, its management services organizations furnish administrative, operational, and support assistance to its associated hospitals and physician groups. A proprietary, cloud-based technology platform within this division is crucial; it aggregates patient and provider data from multiple information systems, settings, and sources to construct a holistic view, thereby enabling more effective care delivery. The company maintains its corporate headquarters in Houston, Texas.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021	FY 2020 12/31/2020	FY 2019 12/31/2019	FY 2018 12/31/2018
Total Revenue	847	875	480	—	—	—	—	—	—
Cost of Goods Sold Incl. D&A	413	431	284	—	—	—	—	—	—
Gross Profit	434	444	196	—	—	—	—	—	—
Selling, General and Administrative Excl. Other	60	169	59	—	—	—	—	—	—
Research and Development	0	0	0	—	—	—	—	—	—
Other Operating Expense	7	0	7	—	—	—	—	—	—
Operating Income	364	276	131	—	—	—	—	—	—
Interest Expense	20	22	20	—	—	—	—	—	—
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	-1	-9	-1	—	—	—	—	—	—
Net Income Before Taxes	344	245	110	—	—	—	—	—	—
Income Taxes	71	64	14	—	—	—	—	—	—
Consolidated Net Income	180	71	52	—	—	—	—	—	—
Net Income From Continuing Operations	243	180	95	—	—	—	—	—	—
Net Income	180	71	52	—	—	—	—	—	—
EPS (Recurring)	26.48	11.13	10.23	—	—	—	—	—	—
EPS (Basic, Before Extraordinaries)	26.48	11.13	10.23	—	—	—	—	—	—
EPS (Diluted)	25.07	10.48	9.71	—	—	—	—	—	—
EBITDA	354	288	149	—	—	—	—	—	—
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	7.72	15.71	3.26	—	—	—	—	—	—
Price To Sales Ratio	1.60	1.13	0.33	—	—	—	—	—	—
Gross Margin	51.24	50.74	40.83	—	—	—	—	—	—
Operating Margin	42.98	31.54	27.29	—	—	—	—	—	—
Net Margin	21.25	8.11	10.83	—	—	—	—	—	—
Shares Outstanding	7	6	5	—	—	—	—	—	—
Market Capitalization	1,355	988	158	—	—	—	—	—	—
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Saunders Scott J	Director	Jul 31 '26	Option Exercise	0.00	603	0	603	Aug 03
Reed Michael Lee	Director	Jul 31 '26	Option Exercise	0.00	603	0	670	Aug 03
Jaumot Frank E	Director	Jul 31 '26	Option Exercise	0.00	603	0	753	Aug 03
Grenas Cheryl Yvonne	Director	Jul 31 '26	Option Exercise	0.00	603	0	670	Aug 03
Vo Thomas T.	Chief Executive Officer	Mar 10 '26	Option Exercise	0.00	18,016	0	1,846,213	Apr 10
Bamburg Wesley Shane	Chief Operating Officer	Mar 11 '26	Option Exercise	0.00	2,411	0	2,411	Mar 24
Jaumot Frank E	Director	Mar 20 '26	Buy	93.56	150	14,033	150	Mar 23
Hosseinion Warren	President	Mar 19 '26	Buy	94.07	252	23,706	7,765	Mar 23
Hosseinion Warren	President	Mar 10 '26	Option Exercise	0.00	13,605	0	15,739	Mar 23
Spears Kelvin	Director	Mar 17 '26	Buy	94.46	10	945	32,137	Mar 18
Spears Kelvin	Director	Mar 10 '26	Option Exercise	0.00	415	0	32,209	Mar 18
Montgomery Pamela W.	Chief Legal Officer-Healthcare	Mar 13 '26	Buy	88.87	79	7,021	2,758	Mar 16
Montgomery Pamela W.	Chief Legal Officer-Healthcare	Mar 10 '26	Option Exercise	0.00	5,132	0	5,217	Mar 16
Bates Jon Christian	Chief Financial Officer	Mar 11 '26	Option Exercise	0.00	1,694	0	5,527	Mar 11
Luqman Elisa V	Chief Legal Officer - SEC	Mar 10 '26	Option Exercise	0.00	3,609	0	4,441	Mar 11

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.